Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 1997

View Archived Issues

Bexxar now administered on outpatient basis

BioFocus and RDW begin collaboration for T-cell enzyme inhibitors

Safety study of Multikine in prostate cancer patients completed

PolyHeme blood substitute advances to phase III

Another Isis oligonucleotide enters clinical testing

Genzyme Transgenics, Bristol-Myers Squibb to codevelop second recombinant transgenic drug

Ortec's CCS advances in clinical development

Diatide's NDA for venous thrombosis detection kit accepted by FDA

NovaDx and REAADS Medical Products to merge

Tachykinin receptor antagonists developed at Janssen

RPR discloses new factor Xa inhibitors

Agents for enhancing erythropoiesis prepared at SmithKline Beecham

Bayer discloses inhibitors of leukotriene synthesis

SAR reported by Parke-Davis for series of N-type Ca2+ antagonists

LG Chemical characterizes new thrombin inhibitor

Excellent penetration of active parent compound in BALF following administration of GS-4104

Heat treatment for liver cancer assessed in clinical trials

Promising preliminary results obtained with Arthrovas in osteoarthritis

U.S. patent for antithrombotic agents issued to Burnham Institute

Reteplase and alteplase exhibit different profiles of fibrin binding at high doses

Letrozole approved in Canada

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...